Status message

Submissions for this form are closed.

AMIA 2014 Corporate Roundtable Registration

AMIA Corporate Roundtables are fully catered events hosted by organizations looking to engage directly with leaders in the field. Participation in Corporate Roundtables is voluntary and based on your interest in the topic and availability. These events allow you to provide feedback on corporate strategies, inform product development, and learn what important biomedical and health informatics issues these companies are exploring.

Roundtables are by invitation only and are not eligible for CME/CE.

Please consider joining up to three roundtables from the registration list below. Click on the dates to learn more about the roundtables available at those times.

At-a-Glance AMIA 2014 Corporate Roundtable

Monday, November 17, 7:00 a.m. – 8:30 a.m.

MEDITECH

Room: L’Enfant, Lobby Level
Topic: Population Health Management: Risk Stratification & Care Management
Speaker: Dr. Jeffrey Kosowsky, MD, MEDITECH Physician Consultant

Population Health Management is being proposed as a holistic solution to deliver the Triple Aim of promoting the health of populations while simultaneously improving quality and patient experience and reducing the overall cost of care. In this roundtable, we explore how a combination of risk stratification and care management solutions can identify, manage, and monitor candidate populations offering the highest return on health care investment. After laying out the framework, we will explore the interaction between the analytic and management components with a conceptual demo. We will conclude with an open discussion about current efforts and experiences in Population Health Management.

Monday, November 17, 12:00 p.m. – 1:30 p.m.

Cerner

Room: L’Enfant, Lobby Level
Topic: Population Health Management – The Next Generation of Solutions and Platform
Speakers: Dr. David McCallie, SVP, Medical Informatics, Cerner; Dr. Bharat Sutariya, VP & Chief Medical Officer, Cerner
Target Audience: CMIO, CMO, Clinical Informatics Experts, Consumer Informatics Specialists, Health System

As more and more provider organizations are moving toward shared and global risk payment models, there is an ever-increasing need for shared decision-making. The process must provide broader context and deeper intelligence across the continuum of care by the entire care team, including the individual, as member care becomes more important than ever. This interactive session will focus on solutions to these challenges with a discussion of HealtheIntent™, Cerner’s multi-purpose, programmable Population Health Platform. The session will illustrate how this platform integrates vital intelligence capabilities into workflow applications of actual providers and members. The session will include insights from clinical and informatics leaders regarding the best ways to leverage this intelligence at the point of care in a variety of end-user applications, with particular emphasis on SMART and FHIR. The session will further explore key questions facing each organization on your population health management journey.

  • How does your organization transition from aggregating data used for analytics purposes to leveraging big data to engaging members and managing your populations?
  • How does your organization integrate financial and other sources beyond your EMR - at the point of care - to achieve optimal clinical and financial outcomes?
  • How does your organization coordinate and manage care using non-physician providers?

Deloitte

Room: Morgan, Lobby Level
Topic: Applied Analytics: Making the Unicorn Real
Speakers: Fred Lee, VP of Healthcare Analytics and Specialist Leader at ConvergeHEALTH by Deloitte, Tom Davenport, President’s Distinguished Professor of Information Technology and Management at Babson College and Independent Senior Advisor to Deloitte Analytics

An analytics-driven healthcare organization is similar to a unicorn in that each can be described, but neither has ever been seen before. While much of the industry’s attention is currently on the technology required to enable the use of analytics, achieving the future state requires not only technical solutions, but also data science capabilities and professional services. These requirements are key to address true organizational transformation by incorporating a rich ecosystem of partners, as well as opportunities to create new business models around healthcare knowledge management.

Join Deloitte and Tom Davenport, author of Competing on Analytics, for a roundtable discussion about considerations, opportunities, and caveats that the healthcare industry will experience as it matures in its use of analytics, migrating from analytics being used as a tool to analytics becoming deeply embedded and integral to care delivery, research, and performance improvement.

First Databank (FDB)

Room: Northwest, Lobby Level
Topic: Transforming the Approach Toward Optimal Medication Decision Support
Speakers: Charles Tuchinda, MD MBA, Executive Vice President, FDB (First Databank, Inc.)
Target Audience: CMIOs, decision support subject matter experts, clinical informaticists, other physicians)

Medication alerts and clinical decision support (CDS) have the potential to prevent errors and optimize drug therapy. However, it is widely acknowledged that the lack of specificity of many alerts, and the corresponding over-alerting, reduces that potential. Join us for our 2014 First Databank (FDB) AMIA Roundtable to discuss which medication–related issues faced in daily practice could benefit most from alternative and more specific decision support. Discussion will focus on leveraging additional inputs and refocusing medication CDS in terms of timing, specific challenges (e.g., statin order reminders upon discharge for certain patients), place in the workflow and role. Bring us your real-life challenges with delivering optimal medication therapy and preventing medication–related problems and make your mark on the content you and your organizing will be using next.

In this session we will:

  • Ask for your input on specifically which medication issues faced in daily practice would be most useful to address with practical, more specific medication decision support. Which medication content areas would help you most in managing the changes in healthcare delivery and payment?
  • Ask for your input on the most appropriate places in the workflow to provide new kinds of decision support on medications.
  • Ask for your input on prioritizing our roadmap in relation to new types of medication rules.

IMO

Room: Piscataway, Lobby Level
Topic: How the New IMO 2.x Interoperable Terminology Platform Creates Opportunities in Today’s Frenetic Healthcare Environment
Speakers: Frank Naeymi-Rad, PhD, MS, MBA, CEO and Chairman, IMO; Regis Charlot, MS, Chief Technology Officer and President, IMO; Andrew S. Kanter, MD, MPH, Chief Medical Officer, IMO; Eric Rose, MD, Director of Clinical Terminology; Steve Labkoff, MD, FACP, Vice-President of Pharmaceutical Development; Theresa Rihanek, MHA, RHIA, CCS, Classification and Intervention Mapping Lead – International
Target Audience: CMIO’s, CIO’s, CMO’s and CQO’s

For true interoperability to be realized, there is a pressing need for a proven terminology platform that provides rapid and trusted access across multiple systems and environments. Changes in terminologies, coding and the regulatory landscape demand the flexibility and scalability of a system that supports outcomes analytics plus the addition of new knowledge, including genomics and population health data. Only a system that is this advanced will allow provider organizations to thrive in a healthcare environment in a constant state of change. IMO, the market leader in terminology solutions for electronic health records systems will conduct a roundtable and focus group to share how medical centers and provider systems manage terminology standardization and change in today’s healthcare environment. IMO studies best practices of each healthcare IT vendor and how IMO’s terminology products and services can help customers with their transition to ICD-10.

Linguamatics

Room: Oak Lawn, Lobby Level
Topic: Clinical NLP for Meaningful Use, Patient Screening and Clinical Risk Models: Challenges and Opportunities
Speakers: Dr David Milward, CTO, Linguamatics; Simon Beaulah, Director, Healthcare Strategy, Linguamatics

The demand for detailed patient data in healthcare is being driven by the need for more insights into population patterns, comparative effectiveness and improved efficiency to address rising healthcare costs, changing reimbursement models and the impact of Meaningful Use. Natural Language Processing has long been used in clinical application for disease coding and clinical document improvement, but is seeing significant interest in supporting near real time applications in clinical environments because it can provide access to specific data buried in unstructured text, including HL7 messages. Applications in this space include:

  • Predictive modeling – Re-hospitalization assessment/Pulmonary module risk assessment
  • Information retrieval and ranking – matching patients to available clinical trials from ClinicalTrials.gov
  • Information extraction – improving patient care, clinical pathway adherence and clinical efficiency by analysing unstructured and semi-structured data

This round table will focus on discussing the key goals, benefits and challenges in applying clinical NLP and will include examples of their application and best practice

Tuesday, November 18, 7:00 a.m. – 8:30 a.m.

Clinovations

Room: L’Enfant, Lobby Level
Topic: Provider Engagement Strategies to Support Clinical Transformation Speakers: Trenor Williams, MD, CEO & Co-founder, Clinovations
Target Audience: Hospital and Health System CEOs, CIOs, CMIOs, CMOs, and Population Health Executives

Approximately 44% of acute care hospitals have adopted at least a basic EHR, however 67% of health IT-adopting physicians think that time spent working within the EHR during an exam disrupts patient interactions. Care delivery models are evolving, calling for the creation of new systems and infrastructures to extend across populations of patients.

Join us for a small group, interactive session where we will explore integrated, thoughtful approaches to drive patient-centered care and discuss strategies for engaging clinicians in health IT initiatives. We will focus on how to develop the competencies necessary for successful population health management and true clinical transformation, such as:

  • Patient Outreach & Engagement
  • Metrics/Performance Improvement
  • Provider Incentive Management & Alignment
  • Analytics and Patient Segmentation/Stratification
  • Team-based Care Delivery

Relevant case studies around the benefits of engaging clinicians in an organization’s Annual Wellness Visit and Hierarchical Condition Categories (HCC) Complexity Capture initiatives will be discussed; benefits include the expected increase in revenue capture for accurately coding patient complexity as well as improvement in operational efficiency and clinical excellence.

Surescripts

Room: Northwest, Lobby Level
Topic: Clinical Opportunities for Comprehensive Medication History
Speakers: David Yakimischak, EVP & General Manager, Medication Network Services, Surescripts; Shahid Shah, CTO and Chairman, IMN HealthIMPACT Conferences; Kenneth D. Mandl, MD, MPH, Professor/Chair in Biomedical Informatics and Population Health, Children’s Hospital Informatics Program, Boston Children’s Hospital Center for Biomedical Informatics, Harvard Medical School
Target Audience: CIOs, CMIOs, CQOs, Prescribers, Pharmacists

Poor adherence to medications is responsible for over 125,000 deaths in the United States each year, and an estimated annual cost of $100 billion to $289 billion. Comprehensive Medication History contains data that can identify gaps in care and create actionable intelligence for use in treating patients at risk of harm from poor adherence. At this Roundtable you will hear from two prominent industry leaders who will each share their thoughts about working with Surescripts’ Medication History: What they have done so far, what opportunities are possible given access to more comprehensive data, and the required permissions necessary to use the data.

Bottom Line: Surescripts is interested in new and innovative ways to use medication history. Join us to hear what others are thinking, and to share your ideas with us.

Tuesday, November 18, 12:00 p.m. – 1:30 p.m.

HP

Room: L’Enfant, Lobby Level
Topic: The future of Health Information Exchange and Interoperability
Speakers: Omar Bouhaddou, David Gilbertson
Target Audience: ALL

Electronic Health Records interoperability and Health Information Exchange (HIE) will become a commodity necessary to foster Patient-Driven healthcare and enhance provider adoption. Advances in cloud, mobility, big data and security provide opportunities to accelerate healthcare transformation by reducing the dependencies on traditional institutional boundaries and systems. HP and its clients are developing new avenues to create, secure, manage, and share health data, internally and externally so that information, knowledge, and wisdom could become shared assets in support of patient-centered, team-based, safe and cost-effective care. Attendees will participate in a lively debate about HIE technology (patient matching, consent management, data ownership, data quality, standards (CCDA)), behavior (patient and provider adoption, consumer driven change, workflow), business (return on investment) and policies (privacy, liability, incorporating) that are likely to lead to true sharing of comprehensive health status and interoperability. This roundtable will use a debate format to facilitate the discussion. Two sides will present their perspectives on achieving their vision of the future. The facilitator will invite audience participation in the debate by asking probing questions, providing supporting or conflicting information, or offering an alternative perspective.

Oracle

Room: Northwest, Lobby Level
Topic: Oracle’s Enterprise Healthcare Analytics and the Digital Safety Net
Speaker: Lesli Adams

Join us at AMIA on Tuesday, November 18 at 12:00 for lunch and an exciting discussion on how Oracle Analytics moves data points to information to decision support and fulfills the digital patient safety net at leading Academic Medical Centers.

Pfizer

Room: Oak Lawn, Lobby Level
Topic: An Innovative Population Health Management Platform, Incorporating Natural Language Processing (NLP), Aimed to Improve Quality Care Outcomes
Speakers: Carolyn Ceresola, Care Manager, Shah Medical Associates; Nitzan Sneh, CEO, CliniWorks, Inc.; Pamela Smith, Medical Outcomes Specialist, Pfizer, Inc.; Nicole Ansani, Medical Director – Portfolio Medical Team, Pfizer, Inc.
Target Audience: CMO, CQO, CMIO, Quality or Medical Directors of Large and mid-sized medical Groups

There is continued growth and emphasis on the quality of care and improved patient outcomes in medical group practices. However, there are significant challenges in providing actionable, quality analytics that include: the need to incorporate numerous data sources; un-mineable data in free-text form; time lags in the reported data; and the inability to easily stratify, target and intervene with populations at risk.

This round table will describe a novel analytics platform that incorporates disparate data sources, NLP techniques, and advanced algorithms that address these challenges. Specifically, this roundtable will include discussion and audience feedback on the following topics:

  • NLP – Improving the identification of at-risk populations and associated quality outcomes analysis
    • Analyze the impact the NLP of unstructured/free text on quality analytics
  • Enhancing baseline quality analytics to improve quality gap identification
    • Evaluate the ability of the platform to leverage more complete, comprehensive, near real-time clinical data to target at risk populations and close quality gaps
  • Determining what information is needed to make informed decisions regarding resource allocation and process change based on population health data.

The NLP and technology platform was provided by CliniWorks, an Alliance partner with Pfizer, Inc. to aggregate various data sources, process and database all tracked outcomes into an organization-wide data management and search system. This case study was conducted in collaboration with Shah Medical Associates with funding and analytic support provided by Pfizer and CliniWorks.

Wolters Kluwer Health

Room: Piscataway, Lobby Level
Topic: The Early Detection of Sepsis through Automation, to Help Improve Outcomes and Decrease Costs
Speakers: Sean Benson (VP Innovation; Sharad Manaktala, MD, PhD (Physician Informaticist)

CMS recently joined several states in prioritizing the need to get control of alarming rates of septicemia (sepsis). Despite the significant human (nearly 260,000 deaths annually in the U.S. alone) and financial ($20 billion in treatment costs) tolls of sepsis, the issues preventing early detection and treatment remain numerous. Delayed and sometimes inadequate treatment, problematic cross-shift communications, diagnosis challenges in lower-acuity areas, lack of protocols and limited financial resources, all contribute to this persistent issue. For the past year, Wolters Kluwer has been piloting what it believes to be a robust solution to the issues related to sepsis care. POC Advisor™ is an integrated platform that takes a standardized, multi-disciplinary approach to accelerating diagnosis and the appropriate treatment of sepsis.

During this session, we will share the results of our pilot work and we’ll seek to measure the emphasis individual hospitals place on reducing sepsis rates, its priority versus other initiatives, the perceived value of POC Advisor, implementation challenges and other roadblocks that could potentially hamper widespread adoption of the platform. The session will further provide a platform for the collection of new and unique ideas concerning the POC Advisor development roadmap.

To request an invitation for one or more roundtables, complete the form below. There is no additional fee to attend a roundtable, however you must complete the form to be considered. By completing the form, you understand that the sponsoring organization of your requested roundtable(s) will receive your personal information and may contact you. Only registered Annual Symposium attendees may participate in roundtables.